CCM
WST icon

Carderock Capital Management’s West Pharmaceutical WST Stock Holding History

Carderock Capital Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-19,624
Closed -$7.77M – 75
2024
Q1 		$7.77M Buy
19,624
+6,591
+51% +$2.44M 2.18% 20
2023
Q4 		$4.59M Buy
+13,033
New +$4.61M 1.27% 42

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Carderock Capital Management's WST Position: Q2 2024 in Review

Carderock Capital Management sold out of West Pharmaceutical (WST) in Q2 2024, closing a stake of 19,624 shares — an estimated $7.77M sold.

Carderock Capital Management first reported a position in WST in Q4 2023 and held it in 2 quarters. The position peaked at $7.77M in Q1 2024. 777 funds tracked by Wall St. Rank hold WST as of Q2 2024.

  • Carderock Capital Management reported no remaining West Pharmaceutical position as of Q2 2024 after selling out during the quarter.
  • Carderock Capital Management sold 19,624 West Pharmaceutical shares in Q2 2024, an estimated $7.77M.
  • Carderock Capital Management first reported a position in West Pharmaceutical in Q4 2023 and held it in 2 quarters.
  • Carderock Capital Management's West Pharmaceutical position peaked at $7.77M in Q1 2024.
  • 777 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2024.

Based on Carderock Capital Management's 13F filing for Q2 2024, filed 22 Jul 2024.